世界のゲノミクス市場2023年-2027年

【英語タイトル】Global Genomics Market 2023-2027

Technavioが出版した調査資料(IRTNTR40876-23)・商品コード:IRTNTR40876-23
・発行会社(調査会社):Technavio
・発行日:2023年1月4日
・ページ数:163
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:北米、ヨーロッパ、アジア、その他地域
・産業分野:バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥380,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥608,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Technavio社の本調査レポートによると、世界のゲノミクス市場規模が2022年から2027年まで年平均10.53%成長し、18244.34百万ドルに達すると予測されています。本書では、ゲノミクスの世界市場を調査対象とし、エグゼクティブサマリー、市場状況、市場規模予測、過去の市場規模、ファイブフォース分析、ソリューション別(製品、サービス)分析、用途別(診断薬、創薬、その他)分析、顧客状況、地域別状況(北米、ヨーロッパ、アジア太平洋、その他地域、アメリカ、中国、イギリス、ドイツ、フランス)分析、推進要因・課題・動向、企業状況、企業分析などの項目を掲載しています。なお、本書には、主要企業として10X Genomics Inc.、Abcam plc、Agilent Technologies Inc.、Becton Dickinson and Co.、BGI Genomics Co. Ltd.、Bio Rad Laboratories Inc.、Danaher Corp.、Eppendorf SE、F. Hoffmann La Roche Ltd.、Hamilton Bonaduz AG、Illumina Inc.、Myriad Genetics Inc.、New England Biolabs Inc.、Oxford Nanopore Technologies plc、Pacific Biosciences of California Inc.、Promega Corp.、QIAGEN NV、Standard BioTools Inc.、Thermo Fisher Scientific Inc.、Perkin Elmer Incなどの企業情報が含まれています。
・エグゼクティブサマリー
・市場状況
・市場規模予測
・過去の市場規模
・ファイブフォース分析
・世界のゲノミクス市場規模:ソリューション別
- 製品の市場規模
- サービスの市場規模
・世界のゲノミクス市場規模:用途別
- 診断薬における市場規模
- 創薬における市場規模
- その他用途における市場規模
・顧客状況
・世界のゲノミクス市場規模:地域別 
- 北米のゲノミクス市場規模
- ヨーロッパのゲノミクス市場規模
- アジア太平洋のゲノミクス市場規模
- その他地域のゲノミクス市場規模
- アメリカのゲノミクス市場規模
- 中国のゲノミクス市場規模
- イギリスのゲノミクス市場規模
- ドイツのゲノミクス市場規模
- フランスのゲノミクス市場規模
・推進要因・課題・動向
・企業状況
・企業分析

Technavio社は、利益、価格、競争、プロモーションなどの主要なパラメーターを分析することにより、また複数のソースからのデータを調査、統合、および合計することにより、市場の詳細な全体像を提示します。主要産業のインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは包括的​​で信頼性が高く、一次および二次の広範な調査の結果です。Technavio社の市場調査報告書は、正確な市場の成長を予測するための定性的および定量的調査を使用し、完全な競争状況と詳細なベンダー選択方法と分析を提供します。

世界のゲノミクス市場 2023-2027

Technavio社は、ゲノミクス市場をモニターしており、2022年から2027年にかけて18,244.34百万ドルの成長が予測され、予測期間中のCAGRは10.53%で加速すると予測しています。当レポートでは、ゲノミクス市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題に加え、約25のベンダーを網羅したベンダー分析も提供しています。

当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、ゲノミクス研究開発への投資の増加、遺伝子配列決定のコスト削減、ゲノミクスデータベースの作成とアップグレードの需要増加が牽引しています。

Technavioのゲノミクス市場は以下のようにセグメント化されています:

・ソリューション別:
– 製品
– サービス

・用途別:
– 診断
– 創薬
– その他

・地域別:
– 北米
– ヨーロッパ
– アジア
– その他の地域(ROW)

本調査では、今後数年間のゲノミクス市場の成長を促進する主な理由の1つとして、単一細胞ベースのゲノミクス解析の採用が増加していることを挙げています。また、シークエンシング技術の進歩や精密医療と遺伝子治療の発展が、市場の大きな需要につながるとしています。

Technavio社は、複数の情報源からのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。

当レポートでは、ゲノミクス市場について以下の分野をカバーしています:
– ゲノミクス市場のサイジング
– ゲノミクス市場の予測
– ゲノミクス市場の産業分析

Technavio社の確実なベンダー分析は、クライアントが市場でのポジションを向上できるように設計されており、これに沿って本レポートには、10X Genomics Inc., Abcam plc, Agilent Technologies Inc., Becton Dickinson and Co., BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., Danaher Corp., Eppendorf SE, F. Hoffmann La Roche Ltd., Hamilton Bonaduz AG, Illumina Inc., Myriad Genetics Inc., New England Biolabs Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Promega Corp., QIAGEN NV, Standard BioTools Inc., Thermo Fisher Scientific Inc., and Perkin Elmer Incなどの企業情報が含まれています。また、ゲノミクス市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートでは、主要ベンダーの分析に加え、包括的な市場およびベンダーの状況を掲載しています。

Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細な姿を提示します。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Solution
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global genomics market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global genomics market 2017 – 2021 ($ million)
o 4.2 Solution Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Solution Segment 2017 – 2021 ($ million)
o 4.3 Application Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Application Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Solution
o 6.1 Market segments
o Exhibit 30: Chart on Solution – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Solution – Market share 2022-2027 (%)
o 6.2 Comparison by Solution
o Exhibit 32: Chart on Comparison by Solution
o Exhibit 33: Data Table on Comparison by Solution
o 6.3 Products – Market size and forecast 2022-2027
o Exhibit 34: Chart on Products – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Products – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Products – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Products – Year-over-year growth 2022-2027 (%)
o 6.4 Services – Market size and forecast 2022-2027
o Exhibit 38: Chart on Services – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Services – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Services – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Services – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Solution
o Exhibit 42: Market opportunity by Solution ($ million)
• 7 Market Segmentation by Application
o 7.1 Market segments
o Exhibit 43: Chart on Application – Market share 2022-2027 (%)
o Exhibit 44: Data Table on Application – Market share 2022-2027 (%)
o 7.2 Comparison by Application
o Exhibit 45: Chart on Comparison by Application
o Exhibit 46: Data Table on Comparison by Application
o 7.3 Diagnostic – Market size and forecast 2022-2027
o Exhibit 47: Chart on Diagnostic – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Data Table on Diagnostic – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Chart on Diagnostic – Year-over-year growth 2022-2027 (%)
o Exhibit 50: Data Table on Diagnostic – Year-over-year growth 2022-2027 (%)
o 7.4 Drug discovery – Market size and forecast 2022-2027
o Exhibit 51: Chart on Drug discovery – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Data Table on Drug discovery – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Chart on Drug discovery – Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Drug discovery – Year-over-year growth 2022-2027 (%)
o 7.5 Others – Market size and forecast 2022-2027
o Exhibit 55: Chart on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 56: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Application
o Exhibit 59: Market opportunity by Application ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 61: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 63: Chart on Geographic comparison
o Exhibit 64: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 65: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 67: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 68: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 69: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 71: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 73: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 77: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 81: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 China – Market size and forecast 2022-2027
o Exhibit 85: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.9 UK – Market size and forecast 2022-2027
o Exhibit 89: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.10 Germany – Market size and forecast 2022-2027
o Exhibit 93: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.11 France – Market size and forecast 2022-2027
o Exhibit 97: Chart on France – Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on France – Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on France – Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on France – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 101: Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 102: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 104: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 105: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 106: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 107: Matrix on vendor position and classification
o 12.3 10X Genomics Inc.
o Exhibit 108: 10X Genomics Inc. – Overview
o Exhibit 109: 10X Genomics Inc. – Product / Service
o Exhibit 110: 10X Genomics Inc. – Key offerings
o 12.4 Abcam plc
o Exhibit 111: Abcam plc – Overview
o Exhibit 112: Abcam plc – Product / Service
o Exhibit 113: Abcam plc – Key news
o Exhibit 114: Abcam plc – Key offerings
o 12.5 Agilent Technologies Inc.
o Exhibit 115: Agilent Technologies Inc. – Overview
o Exhibit 116: Agilent Technologies Inc. – Business segments
o Exhibit 117: Agilent Technologies Inc. – Key news
o Exhibit 118: Agilent Technologies Inc. – Key offerings
o Exhibit 119: Agilent Technologies Inc. – Segment focus
o 12.6 Becton Dickinson and Co.
o Exhibit 120: Becton Dickinson and Co. – Overview
o Exhibit 121: Becton Dickinson and Co. – Business segments
o Exhibit 122: Becton Dickinson and Co. – Key news
o Exhibit 123: Becton Dickinson and Co. – Key offerings
o Exhibit 124: Becton Dickinson and Co. – Segment focus
o 12.7 BGI Genomics Co. Ltd.
o Exhibit 125: BGI Genomics Co. Ltd. – Overview
o Exhibit 126: BGI Genomics Co. Ltd. – Product / Service
o Exhibit 127: BGI Genomics Co. Ltd. – Key offerings
o 12.8 Bio Rad Laboratories Inc.
o Exhibit 128: Bio Rad Laboratories Inc. – Overview
o Exhibit 129: Bio Rad Laboratories Inc. – Business segments
o Exhibit 130: Bio Rad Laboratories Inc. – Key news
o Exhibit 131: Bio Rad Laboratories Inc. – Key offerings
o Exhibit 132: Bio Rad Laboratories Inc. – Segment focus
o 12.9 Danaher Corp.
o Exhibit 133: Danaher Corp. – Overview
o Exhibit 134: Danaher Corp. – Business segments
o Exhibit 135: Danaher Corp. – Key news
o Exhibit 136: Danaher Corp. – Key offerings
o Exhibit 137: Danaher Corp. – Segment focus
o 12.10 Eppendorf SE
o Exhibit 138: Eppendorf SE – Overview
o Exhibit 139: Eppendorf SE – Product / Service
o Exhibit 140: Eppendorf SE – Key news
o Exhibit 141: Eppendorf SE – Key offerings
o 12.11 F. Hoffmann La Roche Ltd.
o Exhibit 142: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 143: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 144: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 145: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 146: F. Hoffmann La Roche Ltd. – Segment focus
o 12.12 Illumina Inc.
o Exhibit 147: Illumina Inc. – Overview
o Exhibit 148: Illumina Inc. – Business segments
o Exhibit 149: Illumina Inc. – Key news
o Exhibit 150: Illumina Inc. – Key offerings
o Exhibit 151: Illumina Inc. – Segment focus
o 12.13 Myriad Genetics Inc.
o Exhibit 152: Myriad Genetics Inc. – Overview
o Exhibit 153: Myriad Genetics Inc. – Product / Service
o Exhibit 154: Myriad Genetics Inc. – Key offerings
o 12.14 Oxford Nanopore Technologies plc
o Exhibit 155: Oxford Nanopore Technologies plc – Overview
o Exhibit 156: Oxford Nanopore Technologies plc – Product / Service
o Exhibit 157: Oxford Nanopore Technologies plc – Key offerings
o 12.15 Pacific Biosciences of California Inc.
o Exhibit 158: Pacific Biosciences of California Inc. – Overview
o Exhibit 159: Pacific Biosciences of California Inc. – Product / Service
o Exhibit 160: Pacific Biosciences of California Inc. – Key offerings
o 12.16 QIAGEN NV
o Exhibit 161: QIAGEN NV – Overview
o Exhibit 162: QIAGEN NV – Product / Service
o Exhibit 163: QIAGEN NV – Key news
o Exhibit 164: QIAGEN NV – Key offerings
o 12.17 Standard BioTools Inc.
o Exhibit 165: Standard BioTools Inc. – Overview
o Exhibit 166: Standard BioTools Inc. – Product / Service
o Exhibit 167: Standard BioTools Inc. – Key news
o Exhibit 168: Standard BioTools Inc. – Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 169: Inclusions checklist
o Exhibit 170: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 171: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 172: Research methodology
o Exhibit 173: Validation techniques employed for market sizing
o Exhibit 174: Information sources
o 13.5 List of abbreviations
o Exhibit 175: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Solution
Exhibits6: Executive Summary – Chart on Market Segmentation by Application
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global genomics market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Solution Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Application Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Solution – Market share 2022-2027 (%)
Exhibits31: Data Table on Solution – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Solution
Exhibits33: Data Table on Comparison by Solution
Exhibits34: Chart on Products – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Products – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Products – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Products – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Services – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Services – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Services – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Services – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Solution ($ million)
Exhibits43: Chart on Application – Market share 2022-2027 (%)
Exhibits44: Data Table on Application – Market share 2022-2027 (%)
Exhibits45: Chart on Comparison by Application
Exhibits46: Data Table on Comparison by Application
Exhibits47: Chart on Diagnostic – Market size and forecast 2022-2027 ($ million)
Exhibits48: Data Table on Diagnostic – Market size and forecast 2022-2027 ($ million)
Exhibits49: Chart on Diagnostic – Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on Diagnostic – Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Drug discovery – Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Drug discovery – Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Drug discovery – Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Drug discovery – Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits59: Market opportunity by Application ($ million)
Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits61: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits63: Chart on Geographic comparison
Exhibits64: Data Table on Geographic comparison
Exhibits65: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits66: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits67: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on France – Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on France – Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on France – Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on France – Year-over-year growth 2022-2027 (%)
Exhibits101: Market opportunity By Geographical Landscape ($ million)
Exhibits102: Impact of drivers and challenges in 2022 and 2027
Exhibits103: Overview on Criticality of inputs and Factors of differentiation
Exhibits104: Overview on factors of disruption
Exhibits105: Impact of key risks on business
Exhibits106: Vendors covered
Exhibits107: Matrix on vendor position and classification
Exhibits108: 10X Genomics Inc. – Overview
Exhibits109: 10X Genomics Inc. – Product / Service
Exhibits110: 10X Genomics Inc. – Key offerings
Exhibits111: Abcam plc – Overview
Exhibits112: Abcam plc – Product / Service
Exhibits113: Abcam plc – Key news
Exhibits114: Abcam plc – Key offerings
Exhibits115: Agilent Technologies Inc. – Overview
Exhibits116: Agilent Technologies Inc. – Business segments
Exhibits117: Agilent Technologies Inc. – Key news
Exhibits118: Agilent Technologies Inc. – Key offerings
Exhibits119: Agilent Technologies Inc. – Segment focus
Exhibits120: Becton Dickinson and Co. – Overview
Exhibits121: Becton Dickinson and Co. – Business segments
Exhibits122: Becton Dickinson and Co. – Key news
Exhibits123: Becton Dickinson and Co. – Key offerings
Exhibits124: Becton Dickinson and Co. – Segment focus
Exhibits125: BGI Genomics Co. Ltd. – Overview
Exhibits126: BGI Genomics Co. Ltd. – Product / Service
Exhibits127: BGI Genomics Co. Ltd. – Key offerings
Exhibits128: Bio Rad Laboratories Inc. – Overview
Exhibits129: Bio Rad Laboratories Inc. – Business segments
Exhibits130: Bio Rad Laboratories Inc. – Key news
Exhibits131: Bio Rad Laboratories Inc. – Key offerings
Exhibits132: Bio Rad Laboratories Inc. – Segment focus
Exhibits133: Danaher Corp. – Overview
Exhibits134: Danaher Corp. – Business segments
Exhibits135: Danaher Corp. – Key news
Exhibits136: Danaher Corp. – Key offerings
Exhibits137: Danaher Corp. – Segment focus
Exhibits138: Eppendorf SE – Overview
Exhibits139: Eppendorf SE – Product / Service
Exhibits140: Eppendorf SE – Key news
Exhibits141: Eppendorf SE – Key offerings
Exhibits142: F. Hoffmann La Roche Ltd. – Overview
Exhibits143: F. Hoffmann La Roche Ltd. – Business segments
Exhibits144: F. Hoffmann La Roche Ltd. – Key news
Exhibits145: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits146: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits147: Illumina Inc. – Overview
Exhibits148: Illumina Inc. – Business segments
Exhibits149: Illumina Inc. – Key news
Exhibits150: Illumina Inc. – Key offerings
Exhibits151: Illumina Inc. – Segment focus
Exhibits152: Myriad Genetics Inc. – Overview
Exhibits153: Myriad Genetics Inc. – Product / Service
Exhibits154: Myriad Genetics Inc. – Key offerings
Exhibits155: Oxford Nanopore Technologies plc – Overview
Exhibits156: Oxford Nanopore Technologies plc – Product / Service
Exhibits157: Oxford Nanopore Technologies plc – Key offerings
Exhibits158: Pacific Biosciences of California Inc. – Overview
Exhibits159: Pacific Biosciences of California Inc. – Product / Service
Exhibits160: Pacific Biosciences of California Inc. – Key offerings
Exhibits161: QIAGEN NV – Overview
Exhibits162: QIAGEN NV – Product / Service
Exhibits163: QIAGEN NV – Key news
Exhibits164: QIAGEN NV – Key offerings
Exhibits165: Standard BioTools Inc. – Overview
Exhibits166: Standard BioTools Inc. – Product / Service
Exhibits167: Standard BioTools Inc. – Key news
Exhibits168: Standard BioTools Inc. – Key offerings
Exhibits169: Inclusions checklist
Exhibits170: Exclusions checklist
Exhibits171: Currency conversion rates for US$
Exhibits172: Research methodology
Exhibits173: Validation techniques employed for market sizing
Exhibits174: Information sources
Exhibits175: List of abbreviations



★調査レポート[世界のゲノミクス市場2023年-2027年] (コード:IRTNTR40876-23)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のゲノミクス市場2023年-2027年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆